Mechanisms and pathways of bone metastasis: challenges and pitfalls of performing molecular research on patient samples.
The molecular mechanisms underlying the development of bone metastases in breast cancer remain unclear. Disseminated tumour cells (DTCs) in the bone marrow of breast cancer patients are commonly identified, even in early stage disease, but their potential to initiate metastases is not known. The mechanism whereby DTCs become overt metastatic tumour cells (MTCs) is therefore, an area of considerable interest. This study explored the analysable yield of genetic material from human biopsy samples in order to describe differences in gene expression between DTCs and bone MTCs. Thirteen breast cancer patients with bone metastases underwent a CT-guided bone metastasis biopsy and a bone marrow biopsy. Tumour cells were enriched and gene expression profiling was conducted to identify differentially expressed genes. The analysable yield of sufficient RNA for microarray analysis was 60% from bone metastasis biopsies and 80% from bone marrow biopsies. A signature of 133 candidate genes differentially expressed between DTCs and MTCs was identified. Several genes relevant to breast cancer metastasis to bone (osteopontin, CTGF, parathyroid hormone receptor, EGFR) were significantly overexpressed in MTCs as compared to DTCs. Biopsies of bone metastases and bone marrow rarely yield enough tissue for robust molecular biology studies using clinical samples. The findings obtained however are interesting and seem to overlap with the bone metastasis gene expression signature described in murine xenograft models. Larger biopsy specimens or improved RNA extraction techniques may improve analysable yield and feasibility of these techniques.
Cawthorn
T R
TR
Division of Applied Molecular Oncology, Princess Margaret Hospital, Toronto, ON, Canada.
Amir
E
E
Broom
R
R
Freedman
O
O
Gianfelice
D
D
Barth
D
D
Wang
D
D
Holen
I
I
Done
S J
SJ
Clemons
M
M
D000328:Adult; D014408:Biomarkers, Tumor / Q000378:metabolism; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology; D001859:Bone Neoplasms / Q000235:genetics* / Q000556:secondary*; D001943:Breast Neoplasms / Q000235:genetics / Q000473:pathology*; D005240:Feasibility Studies; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008875:Middle Aged; D018365:Neoplasm, Residual / Q000473:pathology; D009360:Neoplastic Cells, Circulating; D011446:Prospective Studies; D012334:RNA, Neoplasm / Q000032:analysis
D014408:Biomarkers, Tumor; D012334:RNA, Neoplasm
N Engl J Med. 2004 Dec 30;351(27):2817-26
15591335
J Clin Oncol. 1998 Jun;16(6):2038-44
9626201
N Engl J Med. 2009 Jan 1;360(1):53-62
19118304
Clin Oncol (R Coll Radiol). 2008 Dec;20(10):763-8
18824337
Cancer. 2000 Mar 1;88(5):1082-90
10699899
Ann Surg Oncol. 2007 Jun;14(6):1896-903
17356955
Cancer. 2001 Jul 1;92(1):46-53
11443608
J Biol Chem. 2007 Sep 14;282(37):26656-26665
17636266
J Clin Oncol. 1999 Mar;17(3):846-54
10071275
Oncologist. 2001;6(2):125-32
11306724
Cancer Cell. 2003 Jun;3(6):537-49
12842083
J Immunol Methods. 2005 May;300(1-2):136-45
15907331
Biochim Biophys Acta. 2009 Aug;1796(1):27-32
19406208
Bioinformatics. 2003 Jan 22;19(2):185-93
12538238
Breast Cancer Res. 2006;8(2):R13
16542503
Nat Biotechnol. 2006 Sep;24(9):1151-61
16964229
Anticancer Res. 1999 Jul-Aug;19(4C):3383-92
10629624
J Clin Oncol. 1996 Sep;14(9):2552-9
8823335
Clin Cancer Res. 2005 May 15;11(10):3678-85
15897564
J Clin Oncol. 2005 May 20;23(15):3314-21
15738536
Cancer Res. 2005 Jun 15;65(12):4993-7
15958538
Diagn Pathol. 2009 Mar 24;4:9
19317905
Nature. 2002 Jan 31;415(6871):530-6
11823860
N Engl J Med. 2005 Aug 25;353(8):793-802
16120859
Ann Oncol. 2009 Sep;20(9):1499-1504
19299408
Cancer Res. 2006 Mar 15;66(6):2918-22
16540638
Ann Oncol. 2008 Dec;19(12):2007-11
18664560
N Engl J Med. 2009 Feb 12;360(7):679-91
19213681
Am J Pathol. 1999 Jan;154(1):61-6
9916919
Cancer. 1997 Oct 15;80(8 Suppl):1588-94
9362426
Cancer. 2004 Aug 15;101(4):693-703
15305398
Clin Cancer Res. 2004 Feb 15;10(4):1392-400
14977842
Breast Cancer Res. 2008;10 Suppl 1:S1
19091005